All In MedTech

Device Trial Radar · NCT06784466

Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation

Coherent Sine Burst Electroporation (CSE) Ablation System US Investigational Device Exemption (IDE) Study for Patients With Atrial Fibrillation

Last checked: Nov 20, 2026Latest source record: Jul 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

360

Planned (sponsor's estimate)

Start

Sep 10, 2025

Primary completion

Jun 2027

Study completion Aug 2027

Sponsor

Lead sponsor
Arga Medtech SANot on our public-company list
Sponsor type
Industry
First posted
Jan 20, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To evaluate the safety and effectiveness of the Argá Medtech CSE Ablation System in the treatment of atrial fibrillation.

Conditions

  • Atrial Fibrillation (AF)
  • Persistant Atrial Fibrillation
  • Paroxysmal AF

Interventions

  • Argá Medtech Coherent Sine-Burst Electroporation (CSE) Ablation SystemDevice

    Ablation using the Argá Medtech Coherent Sine-Burst Electroporation (CSE) Ablation System

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety: Number of Participants With at Least One Primary Safety Event.Time frame: Up to 180 days
  2. Effectiveness: Number of Participants With Treatment Success.Time frame: Up to 12 months

Locations

27 sites in 6 countries. Site status is shown where the registry gives one.

  • Grandview

    Birmingham, Alabama · Recruiting

  • Banner University Med Ctr

    Phoenix, Arizona · Recruiting

  • Arrhythmia Research Group

    Jonesboro, Arkansas · Recruiting

24 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.